Body

Tracking down pathogenic yeasts

Tracking down pathogenic yeasts

Understanding Missouri River's sediment dynamics key to protecting endangered species

Sept. 28, 2010 -- A new report from the National Research Council says that more organized and systematic procedures for gathering and evaluating data on Missouri River sediment are required to improve decisions and better manage the river's ecosystem, including protecting endangered species and developing water quality standards. In addition, the report finds that the U.S.

Asparagus urine odor experiment shows genetic differences in sense of smell

PHILADELPHIA (September 28, 2010) – Scientists at the Monell Center have used a well-known example of individual differences to identify a genetic contribution to the sense of smell.

Most people detect a distinct sulfurous odor in their urine shortly after eating asparagus. However, there are some who seemingly do not notice the unpleasant odor.

Up until now, it has been unclear whether this is because these individuals do not produce the odor or because they cannot smell it.

What next for the 2009 H1N1 influenza pandemic?

WASHINGTON, DC – September 28, 2010 -- Now that the H1N1 influenza pandemic is officially over, what will happen to the virus? In a perspective article published today in the online open-access journal mBio®, scientists from the National Institutes of Health delve into history and explore the fates of other pandemic influenza viruses in order to speculate on the future of the most recent pandemic virus.

Smithsonian researchers find differences between Galapagos and mainland frigatebirds

Smithsonian researchers find differences between Galapagos and mainland frigatebirds

Abatacept found ineffective in treatment of non-life threatening lupus

Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept failed to prevent new disease flares in SLE patients tapered from corticosteroids in an analysis where mild, moderate and severe disease flares were evaluated together. Full details of the phase IIb clinical trial are published in the October issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

Structural Genomics Consortium releases 1,000th protein structure

Structural Genomics Consortium releases 1,000th protein structure

The Structural Genomics Consortium (SGC), an international public-private partnership that aims to determine three dimensional structures of medically important proteins, announced today the release into the public domain of its 1000th high resolution protein structure.

Novel biomarker may predict response to new VEGF receptor inhibitor

DENVER — Researchers believe there may be a way to predict, based on individual tumors, those patients that are more likely to respond to the investigational new drug tivozanib.

This is possible, the researchers from AVEO Pharmaceuticals, Inc. said, because they have used a new way of creating animal tumor models that mimic tumor variation seen in human. Based on the results of these studies, they have found a single biomarker that may predict resistance to tivozanib, an oral, triple VEGF (vascular endothelial growth factor) receptor inhibitor.

'Green' concrete developed at Louisiana Tech University on display at Detroit Science Center

RUSTON, La. – Geopolymer concrete, an innovative and environmentally-friendly building material developed at Louisiana Tech University's Trenchless Technology Center (TTC), will be featured in a transportation exhibition taking place at the Detroit Science Center.

Developed by Dr. Erez Allouche, research director for the TTC, and his team, geopolymer concrete is an emerging class of cementitious materials that utilize "fly ash", one of the most abundant industrial by-products, as a substitute for Portland cement, the most widely produced man-made material on earth.

WMS endorses emergency treatment of anaphylaxis by trained non-medical professionals

Philadelphia, PA, September 28, 2010 – The Epinephrine Roundtable was convened during the 25th Annual Meeting of the Wilderness Medical Society (WMS) in 2008 to explore areas of consensus and uncertainty in the field treatment of anaphylaxis. The panel endorsed the administration of epinephrine to treat anaphylaxis in the field under emergency conditions by trained non-medical professionals. Anaphylaxis, an acute allergic reaction, is sudden in onset and requires immediate treatment.

'Firefly' stem cells may help repair damaged hearts

'Firefly' stem cells may help repair damaged hearts

Stem cells that glow like fireflies could someday help doctors heal damaged hearts without cutting into patients' chests.

New study reveals that insecticides from genetically modified corn are present in adjacent streams

A new study by University of Notre Dame ecologist Jennifer Tank and colleagues reveals that streams throughout the Midwest are receiving transgenic materials from corn crop byproducts, even six months after harvest.

Transgenic maize (corn) has been genetically engineered to produce its own insecticide, a delta endotoxin from the bacterium Bacillus thuringiensis (Bt). Bt endotoxins deter crop pests, such as the European corn borer.

Wasps wage war on behalf of wiliwili trees

A black, two-millimeter-long wasp from East Africa is helping wage war on one of its own kind—the Erythrina gall wasp, an invasive species that's decimated Hawaii's endemic wiliwili (Erythrina sandwicensis) and introduced coral bean trees (Erythrina spp.).

Study finds national debt 'tipping point' that slows economic growth

Researchers from North Carolina State University have identified a "tipping point" for national debt – the point at which national debt levels begin to have an adverse effect on economic growth. The findings could influence economic policy discussions globally, and will be distributed at the upcoming meeting of the International Monetary Fund (IMF) and World Bank Group.

International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving mat

September 28, 2010 (Geneva, Switzerland) – At the UN Millennium Development Goals (MDG) summit in New York this week, world leaders gathered to review progress on the eight goals agreed in 2000 on alleviating world poverty and ill-health by 2015. As the summit came to a close, governments, businesses and aid organisations made commitments totaling $40bn to reach the goals, with particular emphasis on improving maternal and child health.